Gamma Interferon and Breast Cancer Cell Resistance
Author Information
Author(s): N. Jabrane-Ferrat, F. Calvo, A. Faille, J.F. Lagabrielle, N. Boisson, A. Quillet, D. Fradelizi
Primary Institution: Laboratoire de Pharmacologie, Universite Paris 7 et Unite 204 INSERM
Hypothesis
Does gamma interferon treatment increase the resistance of breast cancer cells to immune cell cytotoxicity?
Conclusion
Gamma interferon treatment increases MHC class I expression on breast cancer cells, making them more resistant to destruction by immune cells.
Supporting Evidence
- Gamma interferon treatment increased MHC class I expression on breast cancer cells.
- IFN-y treated cells showed resistance to NK and LAK cell lysis.
- Monoclonal antibodies could restore lysis of IFN-y treated cells.
Takeaway
Gamma interferon helps breast cancer cells hide from the immune system by making them look more normal.
Methodology
The study involved treating breast cancer cell lines with gamma interferon and measuring their susceptibility to immune cell lysis.
Participant Demographics
The study used human breast cancer cell lines T47D and ZR75-1.
Want to read the original?
Access the complete publication on the publisher's website